Physician

Joseph P Mckenna, M.D.

According to 2025 Medicare claims, Joseph Mckenna, M.D. (NPI: 1760411599) practices nephrology in the Muskegon-Norton Shores, MI market, with the plurality of this provider's patient population coming from Muskegon, MI. This provider's primary affiliated billing organization is WEST MICHIGAN NEPHROLOGY PLLC (NPI: 1235143090; TIN: 382690980) and primary practice location at 49444-1881. Mckenna is affiliated with the Trinity Health Integrated Care (ACO ID: A3454) and West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Mckenna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 369 traditional Medicare patients, billed 1,048 HCPCS/CPT codes, and received $140,356 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,126 prescription claims across 352 beneficiaries totaling $171,452 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 29 claims. Open Payments data shows 3 records totaling $53. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $565,693 to $171,452. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $1,117 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	551	1,905	$167,506
2016	608	1,962	$171,339
2017	540	1,782	$159,168
2018	582	1,649	$145,455
2019	594	2,355	$293,486
2020	504	1,735	$213,508
2021	465	1,290	$171,166
2022	429	1,111	$149,709
2023	426	1,188	$151,810
2024	369	1,048	$140,356

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	341	2,441	$565,693
2016	373	2,544	$699,616
2017	407	2,929	$776,984
2018	391	2,257	$397,233
2019	336	1,708	$216,979
2020	279	1,374	$228,582
2021	304	1,222	$205,595
2022	283	974	$128,685
2023	318	1,059	$149,039
2024	352	1,126	$171,452

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	136	$8,920
2016	35	178	$10,800
2017	52	228	$16,742
2018	52	214	$10,556
2019	40	278	$12,047
2020	N/R	26	$534
2021	N/R	64	$2,560
2022	N/R	11	$344
2023	N/R	56	$1,371
2024	N/R	29	$505

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	138	362	$243
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	49	64	$207
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	83	247	$55
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	143	159	$53
90935	Hemodialysis procedure with physician evaluation	44	93	$50

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	49	2,040	$36,405
Lanthanum Carbonate	Lanthanum Carbonate	19	810	$34,898
Lokelma	Sodium Zirconium Cyclosilicate	30	1,154	$10,836
Sevelamer Carbonate	Sevelamer Carbonate	37	2,045	$6,249
Calcium Acetate	Calcium Acetate	39	1,379	$3,915

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	14	$329
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	15	$176

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$53	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Joseph P. Mckenna, M.D.?

Tedicare shows public-source Medicare data for Joseph P. Mckenna, M.D. (NPI 1760411599), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph P. Mckenna, M.D. have ACO affiliation data?

Joseph P. Mckenna, M.D. is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454) and West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Joseph P. Mckenna, M.D.?

Joseph P. Mckenna, M.D. is linked to WEST MICHIGAN NEPHROLOGY PLLC (billing NPI 1235143090) in the available physician profile data.

Does Joseph P. Mckenna, M.D. have Open Payments data?

Joseph P. Mckenna, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.